MedTrace Logo

Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

NCT00433121 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2007-08-24

No results posted yet for this study

Summary

The aim of this study is to discontinue antipsychotics and antidepressants, and to study its effect on Behavioural- and Psychological Symptoms in Dementia (BPSD).

Conditions

Interventions

DRUG

Risperidone

DRUG

Olanzapine

DRUG

Haloperidole

DRUG

Quetiapin

DRUG

Escitalopram

DRUG

Citalopram

DRUG

Sertralin

Sponsors & Collaborators

  • Demensforbundet, Norway

    collaborator UNKNOWN

  • Sykehuset Innlandet HF

    lead OTHER

Principal Investigators

  • Knut Engedal, Ph D · The Norwegian Centre for Dementia Research (NCDR), Norway

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Completion
2007-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00433121 on ClinicalTrials.gov